Experience
👥 No personal reports yet
⚕ No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problem
Titration strategies
No titration strategies yet. Be the first to suggest one.
+ Add a titration strategy
Effects
No effects listed yet. Be the first to suggest one.
+ Add an effect
Interactions
Pharmacokinetic mechanism Substrate / metabolism relationships from primary literature
FDA Drug Interactions Table: sensitive index substrate of CYP2D6.
Rate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice? trivial 1 2 3 4 5 critical
Mechanism description, if it needs work: Outdated Inaccurate Misleading
Is this row worth surfacing? Flag as low-value noise
Your own experience with this combination:
Inferred from pharmacokinetic data Materialised by the inference engine; provenance shown per row
Quinidine pk raises via CYP2D6 Inferred 76 / 100 Rate Quinidine inhibits CYP2D6 (inhibitor_strong, intensity 95); Dextromethorphan is a substrate_major of CYP2D6 (intensity 80). Derived: Dextromethorphan exposure raised.
⏱ reversible competitive, effect resolves over ~5 inhibitor half-livesRate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice? trivial 1 2 3 4 5 critical
Confidence in this inference: is the inferred magnitude sound? overstated 1 2 3 4 5 sound
Mechanism description, if it needs work: Outdated Inaccurate Misleading
Kinetics annotation: Dispute the half-life claim
Is this row worth surfacing? Flag as low-value noise
Your own experience with this combination:
Fluoxetine pk raises via CYP2D6 Inferred 72 / 100 Rate Fluoxetine inhibits CYP2D6 (inhibitor_strong, intensity 90); Dextromethorphan is a substrate_major of CYP2D6 (intensity 80). Derived: Dextromethorphan exposure raised.
⏱ mechanism-based, interaction persists ~4-6 weeks after stopping the inhibitorRate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice? trivial 1 2 3 4 5 critical
Confidence in this inference: is the inferred magnitude sound? overstated 1 2 3 4 5 sound
Mechanism description, if it needs work: Outdated Inaccurate Misleading
Kinetics annotation: Dispute the half-life claim
Is this row worth surfacing? Flag as low-value noise
Your own experience with this combination:
Paroxetine pk raises via CYP2D6 Inferred 72 / 100 Rate Paroxetine inhibits CYP2D6 (inhibitor_strong, intensity 90); Dextromethorphan is a substrate_major of CYP2D6 (intensity 80). Derived: Dextromethorphan exposure raised.
⏱ mechanism-based, interaction persists ~4-6 weeks after stopping the inhibitorRate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice? trivial 1 2 3 4 5 critical
Confidence in this inference: is the inferred magnitude sound? overstated 1 2 3 4 5 sound
Mechanism description, if it needs work: Outdated Inaccurate Misleading
Kinetics annotation: Dispute the half-life claim
Is this row worth surfacing? Flag as low-value noise
Your own experience with this combination:
Bupropion pk raises via CYP2D6 Inferred 68 / 100 Rate Bupropion inhibits CYP2D6 (inhibitor_strong, intensity 85); Dextromethorphan is a substrate_major of CYP2D6 (intensity 80). Derived: Dextromethorphan exposure raised.
⏱ reversible competitive, effect resolves over ~5 inhibitor half-livesRate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice? trivial 1 2 3 4 5 critical
Confidence in this inference: is the inferred magnitude sound? overstated 1 2 3 4 5 sound
Mechanism description, if it needs work: Outdated Inaccurate Misleading
Kinetics annotation: Dispute the half-life claim
Is this row worth surfacing? Flag as low-value noise
Your own experience with this combination:
Mirabegron pk raises via CYP2D6 Inferred 44 / 100 Rate Mirabegron inhibits CYP2D6 (inhibitor_moderate, intensity 55); Dextromethorphan is a substrate_major of CYP2D6 (intensity 80). Derived: Dextromethorphan exposure raised.
Rate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice? trivial 1 2 3 4 5 critical
Confidence in this inference: is the inferred magnitude sound? overstated 1 2 3 4 5 sound
Mechanism description, if it needs work: Outdated Inaccurate Misleading
Is this row worth surfacing? Flag as low-value noise
Your own experience with this combination:
Patient experience No patient-experience reports yet.
+ Add an interaction
Relevant anecdote
No anecdotes yet. Share a relevant one.
+ Add an anecdote
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.